Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-07

FDA Approved: RAMELTEON — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ramelteon (Actavis Pharma, Inc.), resulting in an additional regulatory approval for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

SUPPL AP for RAMELTEON (RAMELTEON)